Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction Led by Professor Celia Morgan Psychedelics Investing
Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms Psychedelics Investing
Awakn Life Sciences Begins Trading on the OTCQB Venture Market Under the Symbol 'AWKNF' on August 12th Psychedelics Investing
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 Psychedelics Investing
Levitee Labs Announces Azim Qazi as Head of Ecommerce and Consumer Packaged Goods Psychedelics Investing
Awakn Life Sciences to Present at the Canaccord Genuity 41st Annual Virtual Growth Conference Psychedelics Investing
Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer Psychedelics Investing
Silo Wellness Brings Marley One Mushrooms to the U.K. Market through Distribution Agreement with LocoSoco Limited Psychedelics Investing
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division Psychedelics Investing
